Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Return on Capital Employed (2016 - 2025)

Rocket Pharmaceuticals (RCKT) has disclosed Return on Capital Employed for 10 consecutive years, with 0.73% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 8.0% to 0.73% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.73% through Dec 2025, down 8.0% year-over-year, with the annual reading at 0.58% for FY2025, 4.0% down from the prior year.
  • Return on Capital Employed hit 0.73% in Q4 2025 for Rocket Pharmaceuticals, down from 0.69% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.28% in Q1 2021 to a low of 0.73% in Q4 2025.
  • Historically, Return on Capital Employed has averaged 0.52% across 5 years, with a median of 0.52% in 2024.
  • Biggest five-year swings in Return on Capital Employed: dropped -19bps in 2024 and later grew 3bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.34% in 2021, then crashed by -48bps to 0.5% in 2022, then grew by 3bps to 0.49% in 2023, then plummeted by -34bps to 0.65% in 2024, then dropped by -12bps to 0.73% in 2025.
  • Business Quant data shows Return on Capital Employed for RCKT at 0.73% in Q4 2025, 0.69% in Q3 2025, and 0.66% in Q2 2025.